Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
ACELRX PHARMACEUTICALS INC (ACRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
05/10/2023 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update"
11/14/2022 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update"
08/11/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/10/2022 8-K Quarterly results
11/15/2021 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals to Acquire Lowell Therapeutics and Reports Third Quarter 2021 Financial Results"
08/16/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results"
08/10/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
03/16/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results"
08/05/2019 8-K Quarterly results
05/08/2019 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results"
11/02/2018 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update"
08/02/2018 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Second Quarter 2018 Financial Results"
08/01/2017 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update",
"AcelRx Pharmaceuticals Reports Successful Outcome of ZALVISO Phase 3 IAP312 Study on Device Functionality"
10/29/2015 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Provides Business Update and Reports Third Quarter and Nine Months 2015 Financial Results"
11/10/2014 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Third Quarter 2014 Financial Results REDWOOD CITY, Calif., November 10, 2014 - AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and nine months ended September 30, 2014. “In the third quarter, we held a meeting with the FDA to discuss the Zalviso CRL received in July. During the meeting we discussed the resubmission of the Zalviso NDA and the steps necessary for the resubmission,” stated Richard King, president and CEO of AcelRx. “In advance of resubmitting our Zalviso NDA, we have agreed with the FDA to submit protocols for the bench testing and a Human Factors Study for t..."
03/05/2014 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results REDWOOD CITY, Calif., March 3, 2014 - AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and twelve months ended December 31, 2013. “AcelRx made strong progress in 2013 with the successful completion of the Zalviso™ Phase 3 program, the filing and acceptance of the NDA for Zalviso, the execution of a commercial partnership agreement with Grunenthal for Zalviso that covers Europe and Australia, and agreement with FDA on a Phase 3 program for ARX-04, an investigational single-dose sublingual sufentanil NanoTab for moderate-to-se..."
05/09/2013 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results"
03/13/2013 8-K Form 8-K - Current report
11/06/2012 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results"
08/13/2012 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results"
05/08/2012 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results"
03/21/2012 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results"
11/08/2011 8-K Form 8-K - Current report
08/12/2011 8-K Form 8-K - Current report
05/16/2011 8-K Form 8-K - Current report
03/25/2011 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy